Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease

Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease

Alzheimer’s disease (AD) is the most common neurodegenerative cause of dementia in the elderly. AD is accompanied by the accumulation of amyloid peptides in the brain parenchyma and in the cerebral vessels. The sporadic form of the AD accounts for about 95% of all cases. It is characterized by a lat...

Full description

Bibliographic Details
Main Authors:	Ilaria eCanobbio, Aisha Alsheikh Abubaker, Caterina eVisconte, Mauro eTorti, Giordano ePula
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-03-01
Series:	Frontiers in Cellular Neuroscience
Subjects:	Alzheimer’s disease platelets cerebrovascular disease vascular cells amyloid peptides
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fncel.2015.00065/full

Similar Items

Amyloid Peptide β1-42 Induces Integrin αIIbβ3 Activation, Platelet Adhesion, and Thrombus Formation in a NADPH Oxidase-Dependent Manner
by: Aisha Alsheikh Abubaker, et al.
Published: (2019-01-01)

Predicting cerebral amyloid angiopathy-realated intracerebral hemorrhages and other cerebrovascular disorders in Alzheimer’s disease
by: Masahito eYamada
Published: (2012-04-01)

Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
by: Isabelle Bos, et al.
Published: (2017-12-01)

Cerebrovascular medin is associated with Alzheimer's disease and vascular dementia
by: Raymond Q. Migrino, et al.
Published: (2020-01-01)

Multimodal neuroimaging study of cerebrovascular disease, amyloid deposition, and neurodegeneration in Alzheimer's disease progression
by: Patrick J. Lao, et al.
Published: (2018-01-01)

β-amyloid oligomers in aging and Alzheimer's disease
by: Kathleen R. Zahs, et al.
Published: (2013-07-01)

Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?
by: Castillo-Carranza DL, et al.
Published: (2013-12-01)

Cerebral Amyloid Angiopathy: Emerging Concepts
by: Masahito Yamada
Published: (2015-01-01)

Key points concerning amyloid infectivity and prion-like neuronal invasion
by: Alba eEspargaró, et al.
Published: (2016-04-01)

The cerebrovascular basement membrane: role in the clearance of β-amyloid and cerebral amyloid angiopathy
by: Alan W. J. Morris, et al.
Published: (2014-09-01)

Modulation of β-Amyloid Fibril Formation in Alzheimer’s Disease by Microglia and Infection
by: Madeleine R. Brown, et al.
Published: (2020-11-01)

β-Amyloid: The Key Peptide in the Pathogenesis of Alzheimer’s Disease
by: Xiaojuan eSun, et al.
Published: (2015-09-01)

In vivo detection of amyloid plaques by gadolinium-stained MRI can be used to demonstrate the efficacy of an anti-amyloid immunotherapy
by: Mathieu D. Santin, et al.
Published: (2016-03-01)

Amyloid accumulation in Down syndrome measured with amyloid load
by: Matthew D. Zammit, et al.
Published: (2020-01-01)

The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders
by: Anuradha Tarafdar, et al.
Published: (2018-11-01)

Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia
by: Dietmar Rudolf Thal, et al.
Published: (2019-11-01)

Amyloid Cascade Hypothesis Perspective on Alzheimer's Disease

MODELIZATION OF AMYLOID FIBRIL SELF-ASSEMBLY
by: V. Trusova, et al.
Published: (2018-04-01)

Amyloid beta and Alzheimer’s Disease: The role of neprilysin-2 in amyloid-beta clearance
by: Robert eMarr, et al.
Published: (2014-08-01)

The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets
by: Xue-mei Qi, et al.
Published: (2017-08-01)

Amyloids: The History of Toxicity and Functionality
by: Elmira I. Yakupova, et al.
Published: (2021-05-01)

PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndrome
by: Matthew D. Zammit, et al.
Published: (2021-03-01)

Alzheimer disease and platelets: how’s that relevant
by: Catricala Silvia, et al.
Published: (2012-09-01)

Top ten discoveries of the year: Neurovascular disease
by: Anna Maria Planas
Published: (2020-01-01)

APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease
by: Zonghua Li, et al.
Published: (2020-11-01)

Development of a Multicomponent Intervention to Prevent Alzheimer's Disease
by: Satoshi Saito, et al.
Published: (2019-05-01)

Don't lose sleep over neurodegeneration-it helps clear amyloid beta
by: John Joseph McKinley, et al.
Published: (2013-12-01)

Role of the N-Terminal Hydrophilic Region of Amyloid Beta Peptide in Amyloidogenesis, Membrane Interaction and Toxicity Associated with Alzheimer’s Disease

Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo
by: Raya Al-Shawi, et al.
Published: (2016-01-01)

Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders
by: Yazan S. Batarseh, et al.
Published: (2016-03-01)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
by: Niklas Mattsson‐Carlgren, et al.
Published: (2021-06-01)

Targeting cytotoxic species in amyloid diseases
by: Lindhagen Persson, Malin
Published: (2012)

Results of Beta Secretase-Inhibitor Clinical Trials Support Amyloid Precursor Protein-Independent Generation of Beta Amyloid in Sporadic Alzheimer’s Disease
by: Vladimir Volloch, et al.
Published: (2018-06-01)

Editorial on, Amyloid-beta clearance in Alzheimer’s disease.
by: Robert eMarr
Published: (2014-11-01)

Amyloid Dysmetabolism Relates to Reduced Glucose Uptake in White Matter Hyperintensities
by: Lisa Flem Kalheim, et al.
Published: (2016-11-01)

Dysregulated Gut Homeostasis Observed Prior to the Accumulation of the Brain Amyloid-β in Tg2576 Mice
by: Pedram Honarpisheh, et al.
Published: (2020-03-01)

Dysregulation of Astrocyte–Neuronal Communication in Alzheimer’s Disease
by: Carmen Nanclares, et al.
Published: (2021-07-01)

New therapeutic approaches for Alzheimer’s disease and cerebral amyloid angiopathy
by: Satoshi eSaito, et al.
Published: (2014-10-01)

Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier – phenotypic variability in autosomal dominant Alzheimer’s disease
by: Grace M. Lloyd, et al.
Published: (2020-03-01)

Structure and Aggregation Mechanisms in Amyloids
by: Zaida L. Almeida, et al.
Published: (2020-03-01)